Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease.

Biotechnology

Pinteon Therapeutics

Pinteon Therapeutics' headquarters in Newton, MA, United States

This department oversees the management and execution of clinical trials, ensuring adherence to regulatory standards and operational efficiency.

Clinical Operations

The Advisory Team at Pinteon Therapeutics consists of a group of experts who provide strategic guidance and insights to advance the development of the novel antibody targeting toxic tau. They leverage their extensive knowledge in neurology, clinical research, and regulatory affairs to inform decision-making, optimize clinical study designs, and ensure alignment with industry standards, ultimately aiming to enhance the therapeutic impact on patients with neurodegenerative diseases.

Advisory Team

This department provides strategic direction and oversight to guide the organization's overall vision and operations.

Executive Leadership

The Leadership Team at Pinteon Therapeutics directs the strategic vision and operational execution of the company’s mission to develop innovative therapies for neurodegenerative diseases. Comprised of industry experts including the Chief Medical Officer and Chief Scientific Officer, the team collaborates on clinical development, funding initiatives, and partnership opportunities to ensure the advancement of their novel antibody therapy. Their collective expertise drives decision-making to enhance patient outcomes and promote the overall success of the organization's research and clinical goals.

��

People (0)

Jobs (0)

Other teams

Advisory Team

Executive Leadership

Leadership Team

��������

People (0)

Jobs (0)

Other teams

Advisory Team

Executive Leadership

Leadership Team

��